An inconvenient hurdle in the practice of nanomedicine is the protein corona, a spontaneous
collection of biomolecular species by nanoparticles in living systems. The protein corona is …

In the last decades, the staggering progress in nanotechnology brought around a wide and
heterogeneous range of nanoparticle-based platforms for the diagnosis and treatment of …

Nanoparticle delivery systems offer advantages over free drugs, in that they increase
solubility and biocompatibility. Nanoparticles can deliver a high payload of therapeutic …

Nanotechnology has recently gained traction in the medical field as a method of targeted
delivery and timed release of therapeutic drugs. As interest in this field grows, design …

While highly promising in medicine, gene therapy requires delivery agents to protect and
target nucleic acid therapeutics. We developed a plant viral siRNA delivery platform making …

In recent years, it has become apparent that cancer nanomedicine's reliance on synthetic
nanoparticles as drug delivery systems has resulted in limited clinical outcomes. This is …

The application of nanoparticles for medical purposes has made enormous strides in
providing new solutions to health problems. The observation that plant virus-based …

Plant virus nanoparticles (PVNPs) have inherent immune stimulatory ability, and have been
investigated as immune adjuvants to stimulate an anti-tumor immune response. The …

Exploring the interactions between the immune system and nanomaterials (NMs) is critical
for designing effective and safe NMs, but large knowledge gaps remain to be filled prior to …

Natural plants have acquired an increasing attention in biomedical research. Recent studies
have revealed that plant-derived nanoparticles (PDNPs), which are nano-sized membrane …